CBIF award for genomics-driven personalized immunotherapy

Connecticut Innovations (CI) has awarded $500,000 from the Connecticut Bioscience Innovation Fund (CBIF) for conducting a clinical trial of genomics-driven personalized immunotherapy in ovarian cancer patients and developing a commercialization strategy of this technology. For more details see http://today.uconn.edu/school-stories/connecticut-innovations-fuels-uconns-development-personalized-ovarian-cancer-therapy/.

Posted by Ion on Thursday, July 21st, 2016.